[A case of gastric cancer with peritoneal dissemination which shows a remarkable efficacy by a weekly administration of paclitaxel intraperitoneally].

Abstract

We treated a 65-year-old female with gastric cancer who underwent peritoneal dissemination after 6 successive weeks of paclitaxel intraperitoneal therapy (90 mg/body), and obtained a disappearance of ascites and a reduction of the primary carcinoma. Operative findings: U ant, type 5, 26x20 mm, por, T2, n1(+), H0, P0, CY0, M0, stage II, and grade 2. A weekly paclitaxel intraperitoneal therapy could be a useful for both peritoneal dissemination and the primary carcinoma of advanced gastric carcinoma.

• Authors: Kiyomi Kato, Ayaki Koide, Masahide Oobu, Kumi Hasegawa, Shoji Maruyama, Itaru Takashima, Takeshi Nagahama, Michio Maruyama, Masakazu Ebuchi
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 31 Issue 11 Pg. 1852-4 (Oct 2004) ISSN: 0385-0684 [Print] Japan
• PMID: 15553737 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Antineoplastic Agents, Phytogenic
• Biomarkers, Tumor
• Paclitaxel

Topics

• Aged
• Antineoplastic Agents, Phytogenic (administration & dosage)
• Biomarkers, Tumor (blood)
• Drug Administration Schedule
• Female
• Humans
• Injections, Intraperitoneal
• Neoplasm Seeding
• Paclitaxel (administration & dosage)
• Peritoneal Neoplasms (drug therapy, secondary)
• Stomach Neoplasms (drug therapy)
• Treatment Outcome